Stay updated on Pembrolizumab SBRT in TKI mRCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.

Latest updates to the Pembrolizumab SBRT in TKI mRCC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedSummary: The page now displays a funding-status notice impacting operations and announces a new software version v3.2.0, replacing v3.1.0.SummaryDifference3%
- Check22 days agoChange DetectedCore page content updated to a new version (v3.1.0) from v3.0.2. No other substantive content changes detected.SummaryDifference0.1%
- Check36 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top link was removed. No other core content or time-sensitive data appears affected.SummaryDifference0.2%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check50 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new medical procedures and therapies related to radiosurgery and therapeutics. Notably, the previous version's references to specific genetic disease resources and certain antineoplastic agents have been removed.SummaryDifference2%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab SBRT in TKI mRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.